*****SPECULATION IS WE COULD GET A SIZEABLE MOVE IN THE STOCK TODAY WITH W EASY 30% GAIN*********************
SET ALERTS FOR A POSSIBLE MOVE TO ABOVE $2
AVERAGE PRICE TARGET $9
AVERAGE RECOMMENDATION buy
LEAP THERAPEUTICS INC.
Leap Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies designed to treat patients with cancer. Its clinical stage programs are DKN-01 and TRX518.
SET ALERTS FOR A POSSIBLE MOVE TO ABOVE $2
AVERAGE PRICE TARGET $9
AVERAGE RECOMMENDATION buy
LEAP THERAPEUTICS INC.
Leap Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies designed to treat patients with cancer. Its clinical stage programs are DKN-01 and TRX518.
⭐⭐⭐ Sign Up for Free ⭐⭐⭐
1) Download our App on Google Play! dexwirenews.com/APP
2) Text Message Notifications: dexwirenews.com/SMS
3) Telegram: t.me/DEXWireNews
4) Follow @DEXWireNews on Social Media
1) Download our App on Google Play! dexwirenews.com/APP
2) Text Message Notifications: dexwirenews.com/SMS
3) Telegram: t.me/DEXWireNews
4) Follow @DEXWireNews on Social Media